In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route

NCT02082379 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Interface Acceptance During Delivery of Aerosol Medicine to an Infant or Child

Interventions

BEHAVIORAL: inhaled normal saline using different interfaces.

Sponsor

Arkansas Children's Hospital Research Institute